OX40 inhibitors may transform atopic dermatitis landscape: GlobalData EP News Bureau Apr 15, 2025 GlobalData highlights how OX40 inhibitors, led by rocatinlimab, could reshape moderate-to-severe atopic dermatitis treatment by…
